The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chinese Patent Medicine Market Research Report 2025
Synopsis
The global Chinese Patent Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chinese Patent Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chinese Patent Medicine.
Report Scope
The Chinese Patent Medicine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chinese Patent Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chinese Patent Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Segment by Type
Syrup
Liquid
Tablet
Others
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chinese Patent Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Chinese Patent Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chinese Patent Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chinese Patent Medicine.
Report Scope
The Chinese Patent Medicine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chinese Patent Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chinese Patent Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
Segment by Type
Syrup
Liquid
Tablet
Others
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chinese Patent Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chinese Patent Medicine Market Overview
1.1 Product Overview and Scope of Chinese Patent Medicine
1.2 Chinese Patent Medicine Segment by Type
1.2.1 Global Chinese Patent Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Syrup
1.2.3 Liquid
1.2.4 Tablet
1.2.5 Others
1.3 Chinese Patent Medicine Segment by Application
1.3.1 Global Chinese Patent Medicine Market Value by Application: (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Chinese Patent Medicine Market Size Estimates and Forecasts
1.4.1 Global Chinese Patent Medicine Revenue 2019-2030
1.4.2 Global Chinese Patent Medicine Sales 2019-2030
1.4.3 Global Chinese Patent Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chinese Patent Medicine Market Competition by Manufacturers
2.1 Global Chinese Patent Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chinese Patent Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chinese Patent Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Chinese Patent Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chinese Patent Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chinese Patent Medicine, Product Type & Application
2.7 Chinese Patent Medicine Market Competitive Situation and Trends
2.7.1 Chinese Patent Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chinese Patent Medicine Players Market Share by Revenue
2.7.3 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chinese Patent Medicine Retrospective Market Scenario by Region
3.1 Global Chinese Patent Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chinese Patent Medicine Global Chinese Patent Medicine Sales by Region: 2019-2030
3.2.1 Global Chinese Patent Medicine Sales by Region: 2019-2024
3.2.2 Global Chinese Patent Medicine Sales by Region: 2025-2030
3.3 Global Chinese Patent Medicine Global Chinese Patent Medicine Revenue by Region: 2019-2030
3.3.1 Global Chinese Patent Medicine Revenue by Region: 2019-2024
3.3.2 Global Chinese Patent Medicine Revenue by Region: 2025-2030
3.4 North America Chinese Patent Medicine Market Facts & Figures by Country
3.4.1 North America Chinese Patent Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chinese Patent Medicine Sales by Country (2019-2030)
3.4.3 North America Chinese Patent Medicine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chinese Patent Medicine Market Facts & Figures by Country
3.5.1 Europe Chinese Patent Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chinese Patent Medicine Sales by Country (2019-2030)
3.5.3 Europe Chinese Patent Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Chinese Patent Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chinese Patent Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Chinese Patent Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Chinese Patent Medicine Market Facts & Figures by Country
3.7.1 Latin America Chinese Patent Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chinese Patent Medicine Sales by Country (2019-2030)
3.7.3 Latin America Chinese Patent Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Chinese Patent Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chinese Patent Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chinese Patent Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Chinese Patent Medicine Sales by Type (2019-2030)
4.1.1 Global Chinese Patent Medicine Sales by Type (2019-2024)
4.1.2 Global Chinese Patent Medicine Sales by Type (2025-2030)
4.1.3 Global Chinese Patent Medicine Sales Market Share by Type (2019-2030)
4.2 Global Chinese Patent Medicine Revenue by Type (2019-2030)
4.2.1 Global Chinese Patent Medicine Revenue by Type (2019-2024)
4.2.2 Global Chinese Patent Medicine Revenue by Type (2025-2030)
4.2.3 Global Chinese Patent Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Chinese Patent Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chinese Patent Medicine Sales by Application (2019-2030)
5.1.1 Global Chinese Patent Medicine Sales by Application (2019-2024)
5.1.2 Global Chinese Patent Medicine Sales by Application (2025-2030)
5.1.3 Global Chinese Patent Medicine Sales Market Share by Application (2019-2030)
5.2 Global Chinese Patent Medicine Revenue by Application (2019-2030)
5.2.1 Global Chinese Patent Medicine Revenue by Application (2019-2024)
5.2.2 Global Chinese Patent Medicine Revenue by Application (2025-2030)
5.2.3 Global Chinese Patent Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Chinese Patent Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shanghai Pharmaceutical (Group) Co., Ltd.
6.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
6.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
6.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.2 China Pharmaceutical Group Corporation
6.2.1 China Pharmaceutical Group Corporation Corporation Information
6.2.2 China Pharmaceutical Group Corporation Description and Business Overview
6.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
6.2.5 China Pharmaceutical Group Corporation Recent Developments/Updates
6.3 Guangzhou Pharmaceutical Group Co., Ltd.
6.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
6.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
6.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.4 Tianjin Pharmaceutical Group Co., Ltd.
6.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
6.4.2 Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
6.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.5 Harbin Pharmaceutical Group Co., Ltd
6.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information
6.5.2 Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
6.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio
6.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
6.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
6.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
6.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
6.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments/Updates
6.7 North China Pharmaceutical Group Co., Ltd.
6.6.1 North China Pharmaceutical Group Co., Ltd. Corporation Information
6.6.2 North China Pharmaceutical Group Co., Ltd. Description and Business Overview
6.6.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.7.5 North China Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
6.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
6.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
6.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.9 Taiji Group Co., Ltd.
6.9.1 Taiji Group Co., Ltd. Corporation Information
6.9.2 Taiji Group Co., Ltd. Description and Business Overview
6.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.9.5 Taiji Group Co., Ltd. Recent Developments/Updates
6.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
6.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
6.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
6.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.11 Nanjing Pharmaceutical Co., Ltd
6.11.1 Nanjing Pharmaceutical Co., Ltd Corporation Information
6.11.2 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Description and Business Overview
6.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
6.11.5 Nanjing Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Chongqing Pharmaceutical Co., Ltd
6.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information
6.12.2 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Description and Business Overview
6.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
6.12.5 Chongqing Pharmaceutical Co., Ltd Recent Developments/Updates
6.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
6.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
6.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.14 Jiangxi Pharmaceutical Group Corporation
6.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information
6.14.2 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Description and Business Overview
6.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
6.14.5 Jiangxi Pharmaceutical Group Corporation Recent Developments/Updates
6.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
6.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
6.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.16 Northeast Pharmaceutical Group Co., Ltd.
6.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information
6.16.2 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Description and Business Overview
6.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
6.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chinese Patent Medicine Industry Chain Analysis
7.2 Chinese Patent Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chinese Patent Medicine Production Mode & Process
7.4 Chinese Patent Medicine Sales and Marketing
7.4.1 Chinese Patent Medicine Sales Channels
7.4.2 Chinese Patent Medicine Distributors
7.5 Chinese Patent Medicine Customers
8 Chinese Patent Medicine Market Dynamics
8.1 Chinese Patent Medicine Industry Trends
8.2 Chinese Patent Medicine Market Drivers
8.3 Chinese Patent Medicine Market Challenges
8.4 Chinese Patent Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chinese Patent Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chinese Patent Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chinese Patent Medicine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chinese Patent Medicine Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Chinese Patent Medicine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chinese Patent Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chinese Patent Medicine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chinese Patent Medicine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chinese Patent Medicine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chinese Patent Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chinese Patent Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Chinese Patent Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chinese Patent Medicine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chinese Patent Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chinese Patent Medicine Sales by Region (2019-2024) & (K MT)
Table 18. Global Chinese Patent Medicine Sales Market Share by Region (2019-2024)
Table 19. Global Chinese Patent Medicine Sales by Region (2025-2030) & (K MT)
Table 20. Global Chinese Patent Medicine Sales Market Share by Region (2025-2030)
Table 21. Global Chinese Patent Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chinese Patent Medicine Revenue Market Share by Region (2019-2024)
Table 23. Global Chinese Patent Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chinese Patent Medicine Revenue Market Share by Region (2025-2030)
Table 25. North America Chinese Patent Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chinese Patent Medicine Sales by Country (2019-2024) & (K MT)
Table 27. North America Chinese Patent Medicine Sales by Country (2025-2030) & (K MT)
Table 28. North America Chinese Patent Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chinese Patent Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chinese Patent Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chinese Patent Medicine Sales by Country (2019-2024) & (K MT)
Table 32. Europe Chinese Patent Medicine Sales by Country (2025-2030) & (K MT)
Table 33. Europe Chinese Patent Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chinese Patent Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chinese Patent Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chinese Patent Medicine Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Chinese Patent Medicine Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Chinese Patent Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chinese Patent Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chinese Patent Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chinese Patent Medicine Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Chinese Patent Medicine Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Chinese Patent Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chinese Patent Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chinese Patent Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chinese Patent Medicine Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Chinese Patent Medicine Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Chinese Patent Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chinese Patent Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chinese Patent Medicine Sales (K MT) by Type (2019-2024)
Table 51. Global Chinese Patent Medicine Sales (K MT) by Type (2025-2030)
Table 52. Global Chinese Patent Medicine Sales Market Share by Type (2019-2024)
Table 53. Global Chinese Patent Medicine Sales Market Share by Type (2025-2030)
Table 54. Global Chinese Patent Medicine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chinese Patent Medicine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chinese Patent Medicine Revenue Market Share by Type (2019-2024)
Table 57. Global Chinese Patent Medicine Revenue Market Share by Type (2025-2030)
Table 58. Global Chinese Patent Medicine Price (USD/MT) by Type (2019-2024)
Table 59. Global Chinese Patent Medicine Price (USD/MT) by Type (2025-2030)
Table 60. Global Chinese Patent Medicine Sales (K MT) by Application (2019-2024)
Table 61. Global Chinese Patent Medicine Sales (K MT) by Application (2025-2030)
Table 62. Global Chinese Patent Medicine Sales Market Share by Application (2019-2024)
Table 63. Global Chinese Patent Medicine Sales Market Share by Application (2025-2030)
Table 64. Global Chinese Patent Medicine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chinese Patent Medicine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chinese Patent Medicine Revenue Market Share by Application (2019-2024)
Table 67. Global Chinese Patent Medicine Revenue Market Share by Application (2025-2030)
Table 68. Global Chinese Patent Medicine Price (USD/MT) by Application (2019-2024)
Table 69. Global Chinese Patent Medicine Price (USD/MT) by Application (2025-2030)
Table 70. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 71. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 72. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product
Table 74. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 75. China Pharmaceutical Group Corporation Corporation Information
Table 76. China Pharmaceutical Group Corporation Description and Business Overview
Table 77. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. China Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 79. China Pharmaceutical Group Corporation Recent Developments/Updates
Table 80. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
Table 81. Guangzhou Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 82. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 84. Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 85. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
Table 86. Tianjin Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 87. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 89. Tianjin Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 90. Harbin Pharmaceutical Group Co., Ltd Corporation Information
Table 91. Harbin Pharmaceutical Group Co., Ltd Description and Business Overview
Table 92. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product
Table 94. Harbin Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 95. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
Table 96. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Business Overview
Table 97. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product
Table 99. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments/Updates
Table 100. North China Pharmaceutical Group Co., Ltd. Corporation Information
Table 101. North China Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 102. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 104. North China Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 105. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
Table 106. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 107. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 109. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 110. Taiji Group Co., Ltd. Corporation Information
Table 111. Taiji Group Co., Ltd. Description and Business Overview
Table 112. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Taiji Group Co., Ltd. Chinese Patent Medicine Product
Table 114. Taiji Group Co., Ltd. Recent Developments/Updates
Table 115. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
Table 116. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 117. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 119. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 120. Nanjing Pharmaceutical Co., Ltd Corporation Information
Table 121. Nanjing Pharmaceutical Co., Ltd Description and Business Overview
Table 122. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 124. Nanjing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 125. Chongqing Pharmaceutical Co., Ltd Corporation Information
Table 126. Chongqing Pharmaceutical Co., Ltd Description and Business Overview
Table 127. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product
Table 129. Chongqing Pharmaceutical Co., Ltd Recent Developments/Updates
Table 130. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
Table 131. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 132. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 134. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 135. Jiangxi Pharmaceutical Group Corporation Corporation Information
Table 136. Jiangxi Pharmaceutical Group Corporation Description and Business Overview
Table 137. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product
Table 139. Jiangxi Pharmaceutical Group Corporation Recent Developments/Updates
Table 140. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
Table 141. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 142. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 143. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 144. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 145. Northeast Pharmaceutical Group Co., Ltd. Corporation Information
Table 146. Northeast Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 147. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 148. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product
Table 149. Northeast Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Chinese Patent Medicine Distributors List
Table 153. Chinese Patent Medicine Customers List
Table 154. Chinese Patent Medicine Market Trends
Table 155. Chinese Patent Medicine Market Drivers
Table 156. Chinese Patent Medicine Market Challenges
Table 157. Chinese Patent Medicine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chinese Patent Medicine
Figure 2. Global Chinese Patent Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chinese Patent Medicine Market Share by Type in 2023 & 2030
Figure 4. Syrup Product Picture
Figure 5. Liquid Product Picture
Figure 6. Tablet Product Picture
Figure 7. Others Product Picture
Figure 8. Global Chinese Patent Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Chinese Patent Medicine Market Share by Application in 2023 & 2030
Figure 10. Online Sales
Figure 11. Offline Sales
Figure 12. Global Chinese Patent Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Chinese Patent Medicine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Chinese Patent Medicine Sales (2019-2030) & (K MT)
Figure 15. Global Chinese Patent Medicine Average Price (USD/MT) & (2019-2030)
Figure 16. Chinese Patent Medicine Report Years Considered
Figure 17. Chinese Patent Medicine Sales Share by Manufacturers in 2023
Figure 18. Global Chinese Patent Medicine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Chinese Patent Medicine Players: Market Share by Revenue in 2023
Figure 20. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Chinese Patent Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Chinese Patent Medicine Sales Market Share by Country (2019-2030)
Figure 23. North America Chinese Patent Medicine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Chinese Patent Medicine Sales Market Share by Country (2019-2030)
Figure 27. Europe Chinese Patent Medicine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Chinese Patent Medicine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region (2019-2030)
Figure 35. China Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Chinese Patent Medicine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Chinese Patent Medicine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Chinese Patent Medicine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Chinese Patent Medicine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Chinese Patent Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Chinese Patent Medicine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Chinese Patent Medicine by Type (2019-2030)
Figure 57. Global Chinese Patent Medicine Price (USD/MT) by Type (2019-2030)
Figure 58. Global Sales Market Share of Chinese Patent Medicine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Chinese Patent Medicine by Application (2019-2030)
Figure 60. Global Chinese Patent Medicine Price (USD/MT) by Application (2019-2030)
Figure 61. Chinese Patent Medicine Value Chain
Figure 62. Chinese Patent Medicine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
